Substituted heterocyclic compounds and methods of use

Details for Australian Patent Application No. 2004285920 (hide)

Owner Amgen Inc.

Inventors Martin, Matthew W.; Elbaum, Daniel; Nunes, Joseph J.

Agent Wrays

Pub. Number AU-A-2004285920

PCT Pub. Number WO2005/042518

Priority 60/513,234 21.10.03 US; 10/969,826 20.10.04 US

Filing date 21 October 2004

Wipo publication date 12 May 2005

International Classifications

A61K 31/505 (2006.01) - Pyrimidines

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042518 Priority application(s): WO2005/042518

7 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285923-Nucleoside compounds for treating viral infections

2004285913-3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety